Daniel O. Clegg

MD | Rheumatologist


 50 N Medical Dr, Salt Lake City
    Utah, 84132-0001

  801-581-7724    Maps & Directions
Daniel O. Clegg is a Salt Lake City, Utah based rheumatologist who is specialized in Rheumatology. Active license number of Daniel O. Clegg for Rheumatology is 162952-1205 in Utah.
Daniel O. Clegg treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Daniel O. Clegg speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Specialization: Rheumatology
Credentials: MD
Gender:Male
Practice Address:50 N Medical Dr, Salt Lake City,
Utah, 84132-0001
Phone:801-581-7724
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1275623860
NPI Enumeration Date: 13 Oct, 2006
NPI Last Update On: 08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Daniel O. Clegg are as mentioned below.
License NumberSpecializationStateStatus
162952-1205Rheumatologist UtahPrimary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Po Box 581700,
Salt Lake City, Utah
Zip: 84158-1700
Phone Number: 801-213-3800
Patients can reach Daniel O. Clegg at 50 N Medical Dr, Salt Lake City, Utah or can call to book an appointment on 801-581-7724. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.

Comments/ Reviews: